Miguel Ángel Gallo Meza

Title: Miguel Ángel Gallo Meza: Innovator in Pharmaceutical Chemistry

Introduction

Miguel Ángel Gallo Meza is a notable inventor based in Granada, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological processes in tumor cells and cells affected by parasitic infections.

Latest Patents

His most recent patent involves pyridinium and quinolinium derivatives. This invention provides compounds that block phosphorylcholine biosynthesis by selectively inhibiting the choline kinase enzyme in tumor cells. The implications of this invention are profound, as it can be applied in the treatment of tumors, parasitic diseases, and diseases caused by viruses and fungi in animals, including humans. Miguel holds 1 patent for this innovative work.

Career Highlights

Throughout his career, Miguel Ángel Gallo Meza has been associated with prestigious institutions such as the University of Granada and the Spanish National Research Council (Consejo Superior de Investigaciones Científicas). His work has been instrumental in advancing research in the pharmaceutical sector.

Collaborations

Miguel has collaborated with esteemed colleagues, including Juan Carlos Lacal Sanjuán and Joaquin Campos Rosa. Their joint efforts have contributed to the success of his research and innovations.

Conclusion

Miguel Ángel Gallo Meza stands out as a significant figure in the realm of pharmaceutical innovations. His work continues to impact the treatment of various diseases, showcasing the importance of research and development in healthcare.